T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
KRONOS Worldwide
KRO
$996M
| $148K | ﹤0.01% |
+16,875
| New | +$149K |
|
2602
Noodles & Co
NDLS
$100M
| $148K | ﹤0.01% |
5,462
+863
| +19% | +$28.2K |
|
|
FSP
2603
Franklin Street Properties
FSP
$46.4M
| $147K | ﹤0.01% |
100,709
+7,692
| +8% | +$10.6K |
|
2604
Organogenesis Holdings
ORGO
$226M
| $146K | ﹤0.01% |
43,886
-5,480
| -11% | -$16.2K |
|
|
PVBC
2605
DELISTED
Provident Bancorp
PVBC
| $146K | ﹤0.01% |
17,600
-2,445
| -12% | -$18.4K |
|
|
DCPH
2606
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $146K | ﹤0.01% |
10,333
-589,342
| -98% | -$8.43M |
|
2607
1-800-Flowers.com
FLWS
$261M
| $145K | ﹤0.01% |
18,531
| – | – |
|
2608
SmartRent
SMRT
$276M
| $144K | ﹤0.01% |
37,349
+15,107
| +68% | +$46.2K |
|
|
BLUE
2609
DELISTED
bluebird bio
BLUE
| $143K | ﹤0.01% |
2,166
+462
| +27% | +$33.8K |
|
2610
GrowGeneration
GRWG
$108M
| $143K | ﹤0.01% |
41,936
+3,377
| +9% | +$12K |
|
|
TWKS
2611
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $142K | ﹤0.01% |
18,759
+5,237
| +39% | +$38.7K |
|
2612
Rush Street Interactive
RSI
$2.85B
| $141K | ﹤0.01% |
45,004
| – | – |
|
|
VTNR
2613
DELISTED
Vertex Energy, Inc
VTNR
| $141K | ﹤0.01% |
22,449
+3,324
| +17% | +$23.4K |
|
|
KREF
2614
KKR Real Estate Finance Trust
KREF
$502M
| $140K | ﹤0.01% |
11,460
+670
| +6% | +$7.54K |
|
2615
ProKidney
PROK
$289M
| $140K | ﹤0.01% |
+12,501
| New | +$133K |
|
2616
Select Water Solutions
WTTR
$2.63B
| $140K | ﹤0.01% |
17,263
+3,748
| +28% | +$28.3K |
|
2617
Aveanna Healthcare
AVAH
$2.46B
| $139K | ﹤0.01% |
81,918
+22,400
| +38% | +$28.1K |
|
|
BCLI
2618
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $139K | ﹤0.01% |
4,480
-2,720
| -38% | -$113K |
|
2619
Gevo
GEVO
$401M
| $139K | ﹤0.01% |
90,957
+11,766
| +15% | +$15.2K |
|
|
AMPS
2620
DELISTED
Altus Power
AMPS
| $138K | ﹤0.01% |
25,488
-4,395
| -15% | -$21.7K |
|
2621
ARKO Corp
ARKO
$505M
| $137K | ﹤0.01% |
17,165
+1,530
| +10% | +$12.2K |
|
2622
Evolv Technologies
EVLV
$1.04B
| $137K | ﹤0.01% |
22,833
+6,401
| +39% | +$30.3K |
|
2623
The Joint Corp
JYNT
$119M
| $137K | ﹤0.01% |
10,106
+103
| +1% | +$1.51K |
|
2624
Repay Holdings
RPAY
$317M
| $136K | ﹤0.01% |
17,279
+1,090
| +7% | +$7.33K |
|
|
STKL
2625
DELISTED
SunOpta
STKL
| $136K | ﹤0.01% |
20,312
+1,928
| +10% | +$14.5K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.